227 related articles for article (PubMed ID: 36393833)
1. The role of KRAS splice variants in cancer biology.
Nuevo-Tapioles C; Philips MR
Front Cell Dev Biol; 2022; 10():1033348. PubMed ID: 36393833
[TBL] [Abstract][Full Text] [Related]
2. Differential functions of the KRAS splice variants.
Kochen Rossi J; Nuevo-Tapioles C; Philips MR
Biochem Soc Trans; 2023 Jun; 51(3):1191-1199. PubMed ID: 37222266
[TBL] [Abstract][Full Text] [Related]
3. KRAS4A directly regulates hexokinase 1.
Amendola CR; Mahaffey JP; Parker SJ; Ahearn IM; Chen WC; Zhou M; Court H; Shi J; Mendoza SL; Morten MJ; Rothenberg E; Gottlieb E; Wadghiri YZ; Possemato R; Hubbard SR; Balmain A; Kimmelman AC; Philips MR
Nature; 2019 Dec; 576(7787):482-486. PubMed ID: 31827279
[TBL] [Abstract][Full Text] [Related]
4. KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform.
Salmón M; Paniagua G; Lechuga CG; Fernández-García F; Zarzuela E; Álvarez-Díaz R; Musteanu M; Guerra C; Caleiras E; Muñoz J; Ortega S; Drosten M; Barbacid M
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301865
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties.
Whitley MJ; Tran TH; Rigby M; Yi M; Dharmaiah S; Waybright TJ; Ramakrishnan N; Perkins S; Taylor T; Messing S; Esposito D; Nissley DV; McCormick F; Stephen AG; Turbyville T; Cornilescu G; Simanshu DK
Sci Adv; 2024 Feb; 10(7):eadj4137. PubMed ID: 38354232
[No Abstract] [Full Text] [Related]
6. Origin and evolution of RAS oncoprotein membrane targeting.
García-España A; Philips MR
Res Sq; 2023 Jan; ():. PubMed ID: 36711820
[TBL] [Abstract][Full Text] [Related]
7. Roles of palmitoylation and the KIKK membrane-targeting motif in leukemogenesis by oncogenic KRAS4A.
Zhao H; Liu P; Zhang R; Wu M; Li D; Zhao X; Zhang C; Jiao B; Chen B; Chen Z; Ren R
J Hematol Oncol; 2015 Dec; 8():132. PubMed ID: 26715448
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
9. Comparative Nucleotide-Dependent Interactome Analysis Reveals Shared and Differential Properties of KRas4a and KRas4b.
Zhang X; Cao J; Miller SP; Jing H; Lin H
ACS Cent Sci; 2018 Jan; 4(1):71-80. PubMed ID: 29392178
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic
Zhang L
Glob Med Genet; 2020 Jun; 7(1):1-2. PubMed ID: 32879916
[TBL] [Abstract][Full Text] [Related]
11. Origin and Evolution of RAS Membrane Targeting.
García-España A; Philips MR
Oncogene; 2023 May; 42(21):1741-1750. PubMed ID: 37031342
[TBL] [Abstract][Full Text] [Related]
12. Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling.
Adams LM; DeHart CJ; Drown BS; Anderson LC; Bocik W; Boja ES; Hiltke TM; Hendrickson CL; Rodriguez H; Caldwell M; Vafabakhsh R; Kelleher NL
J Biol Chem; 2023 Jan; 299(1):102768. PubMed ID: 36470426
[TBL] [Abstract][Full Text] [Related]
13. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab.
Chiari R; Palladino S; Emili R; De Lisa M; Sarti D; Catalano V; Magnani M; Graziano F; Ruzzo A
Sci Rep; 2023 Nov; 13(1):21036. PubMed ID: 38030703
[TBL] [Abstract][Full Text] [Related]
14. Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.
Chen WC; To MD; Westcott PMK; Delrosario R; Kim IJ; Philips M; Tran Q; Bollam SR; Goodarzi H; Bayani N; Mirzoeva O; Balmain A
Nat Commun; 2021 Jul; 12(1):4288. PubMed ID: 34257283
[TBL] [Abstract][Full Text] [Related]
15. Arsenite malignantly transforms human prostate epithelial cells in vitro by gene amplification of mutated KRAS.
Merrick BA; Phadke DP; Bostrom MA; Shah RR; Wright GM; Wang X; Gordon O; Pelch KE; Auerbach SS; Paules RS; DeVito MJ; Waalkes MP; Tokar EJ
PLoS One; 2019; 14(4):e0215504. PubMed ID: 31009485
[TBL] [Abstract][Full Text] [Related]
16. RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains.
Zhou Y; Gorfe AA; Hancock JF
Front Mol Biosci; 2021; 8():686338. PubMed ID: 34222339
[TBL] [Abstract][Full Text] [Related]
17. Ras protein abundance correlates with Ras isoform mutation patterns in cancer.
Hood FE; Sahraoui YM; Jenkins RE; Prior IA
Oncogene; 2023 Apr; 42(15):1224-1232. PubMed ID: 36864243
[TBL] [Abstract][Full Text] [Related]
18. Targeting the RAS-dependent chemoresistance: The Warburg connection.
Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
[TBL] [Abstract][Full Text] [Related]
19. A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions.
Miller SP; Maio G; Zhang X; Badillo Soto FS; Zhu J; Ramirez SZ; Lin H
Mol Cell Proteomics; 2022 Aug; 21(8):100268. PubMed ID: 35839996
[TBL] [Abstract][Full Text] [Related]
20. Quantification of spatiotemporal patterns of Ras isoform expression during development.
Newlaczyl AU; Coulson JM; Prior IA
Sci Rep; 2017 Jan; 7():41297. PubMed ID: 28117393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
